Key result
Mechanism-based neurosensory and neurovascular therapies transform clinical migraine practice and improve outcomes.
Overview of migraine pathogenesis highlighting how decades of neurosensory and neurovascular research have led to mechanism-based therapies that transform clinical practice.
Answers are grounded in this paper and cite their sources.
Supports targeted migraine therapies; leaves open the need for randomized trials to confirm broad clinical impact.
Migraine is a chronic neurovascular disorder characterised by recurrent attacks of moderate-to-severe head pain, accompanied by transient but disabling symptoms such as aura, nausea, vomiting, phonophobia, and photophobia, reflecting the involvement of multiple systems. Migraine affects and disables a large proportion of the global population. The pathogenesis of migraine involves the interplay of genetic and epigenetic factors across complex neurosensory and neurovascular networks. Decades of research have elucidated key components of these pathways, driving the development of mechanism-based therapies that are now transforming clinical practice and substantially improving patients' lives.
No takes yet. Share an insight, caveat, or question.
Tassorelli et al. (2026) conducted a review in Migraine. Mechanism-based therapies derived from research into neurosensory and neurovascular migraine pathways are transforming clinical practice and improving patients' lives.
Synapse has enriched 10 related papers. Consider them for comparative context: